About Duo Oncology
Duo Oncology is a private company based in Pittsburgh, Pennsylvania. It has reported $7,000,005 raised in three offerings on Form D since February 2021. Its chief executive is Sam Rothstein.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 2, 2025 | Jun 10, 2025amended Aug 7, 2026 | $1,625,000of $3.5M target | 13 | $125K | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗2 earlier filings |
| Jan 31, 2023 | Feb 8, 2023amended Aug 11, 2023 | $4,250,005fully sold | 14 | $303K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 3, 2021 | Feb 8, 2021 | $1,125,000of $1.5M target | 1 | $1.1M | Options, Securities on exercise, Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $7,000,005 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Duo Oncology's Form D filed Aug 7, 2026.
JH
ST
SL
Song Li
Co-Founder and director
Also an executive officer, director and promoter at SirnaMed Therapeutics.
Katherine Eichinger
Chief Operating Officer
Joe Gatto
Director
LL
Lusong Luo
Member - BeOne Medicines and director
Earlier filings also listed Robert Ashley (director, last listed Aug 2023) and Jingjing Sun (promoter, last listed Aug 2023).